U.S. market Closed. Opens in 2 hours 37 minutes

MIST | Milestone Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue1.00M5.00M15.00MN/AN/AN/AN/A
Cost of RevenueN/A480.00KN/A376.00K236.00K10.00K8.00K
Gross Profit1.00M4.52M15.00M-376.00K-236.00K-10.00K-8.00K
Operating Expenses62.10M64.64M58.07M50.71M57.88M23.82M8.27M
Selling, General & Admin31.05M24.81M19.40M16.22M15.90M6.97M2.63M
Research & Development31.05M39.83M38.67M34.49M41.98M16.85M5.64M
Other Operating ExpensesN/AN/A7.00MN/AN/AN/AN/A
Operating Income-61.10M-59.64M-43.07M-50.71M-57.88M-23.82M-8.27M
Other Expenses / Income1.41M1.25M220.00K726.00K2.60M711.00K186.00K
Before Tax Income-59.69M-58.39M-42.85M-49.98M-55.28M-23.11M-8.08M
Income Tax ExpensesN/A-1.25M-220.00K-17.00K-56.00K74.00K4.00K
Net Income-59.69M-57.13M-42.63M-49.97M-55.23M-23.18M-8.09M
Interest Expenses2.55MN/AN/A726.00K2.60MN/AN/A
Basic Shares Outstanding42.96M42.45M41.83M29.34M15.78M23.65M23.65M
Diluted Shares Outstanding42.96M42.45M41.83M29.34M15.78M23.65M23.65M
EBITDA-56.84M-58.36M-42.98M-50.71M-57.88M-23.36M-8.26M
EBITDA Margin-5,684.50%-1,167.28%-286.53%0.00%0.00%0.00%0.00%
EBIT-57.13M-58.39M-42.85M-49.26M-52.69M-23.11M-8.08M
EBIT Margin-5,713.10%-1,167.76%-285.69%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙